Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration

NCT00539734 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Age-related Macular Degeneration

Interventions

DRUG: ranibizumab

Sponsor

Prince of Songkla University